Elimination of Mother-to-Child Transmission Publications

The 2016-17 MDHS was the second DHS survey to be conducted in the Maldives in collaboration with the worldwide Demographic and Health Surveys Program. Fieldwork for the survey was carried out from 17 March 2016 to 27 November 2017 covering a national sample of over 6,000 households.

This guideline provides updated recommendations for syphilis screening and treatment for pregnant women based on the most recent evidence and available serologic tests for syphilis.

Drawing upon the Global Health Sector Strategy for Viral Hepatitis (2016–2021) and using the framework of universal health coverage to ensure that no one is left behind, the Action Plan provides a roadmap for priority areas of focus and interventions within the health and related sectors that are needed at the national level to mount an effective and efficient response to prevention, diagnosis, management and care of viral hepatitis.

Infographic on hepatitis produced by WHO Regional Office for the Western Pacific.

The report focuses on hepatitis B and C, which are responsible for 96% of all hepatitis mortality.

The shared maternal, newborn and child health platform can coordinate and integrate interventions to achieve efficiencies and cost-effectively prevent these infections to achieve elimination.

This implementation tool describes the recommended approaches for routine monitoring of toxicity integrated with the national monitoring and evaluation system and targeted approaches to monitoring toxicity to enable enhanced monitoring and reporting of treatment-limiting toxicity to support country implementation and generation of local data.

Viral hepatitis is more prevalent in Asia than other regions. From the survey done among the general population in 2015 in Myanmar, the prevalence of hepatitis B was 6.5% and hepatitis C was 2.7%.

The 67th World Health Assembly in May 2014 approved a resolution to improve the prevention, diagnosis and treatment of viral hepatitis. In November 2014, Myanmar initiated the establishment of a National Hepatitis Control
Program (NHCP) following the resolution set up by the World Health Organization (WHO).

The year 2016 represented a transition in many ways for the global HIV response. Some changes and developments were unequivocally positive, while the impact of others remains uncertain.

These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic HCV and HBV infection. The primary audience for these guidelines are national programme managers in ministries of health and health-care providers in low- and middle-income countries (LMICs) responsible for planning and implementing hepatitis testing, prevention, care and treatment services.